1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Bone Biologics Corporation

Bone Biologics Corporation

BBLGW
Bone Biologics CorporationUS flagNASDAQ Capital Market
9.90
USD
+1.90
- -
1.60MMarket Cap

Income Statement (USD)

APIChatGPT
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
3
12
20
3
3
2
1
1
4
9
4
3
+ Selling, General & Admin
2
8
9
4
3
1
- -
1
2
3
2
2
+ Research & Development
1
4
12
-1
- -
1
- -
- -
2
7
2
1
+ Other Operating Expense
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-3
-12
-20
-3
-3
-2
-1
-1
-4
-9
-4
-3
- Non-Operating (Income) Loss
1
2
5
4
2
1
1
1
-2
- -
- -
- -
+ Interest Expense, Net
1
2
3
4
1
1
1
1
- -
- -
- -
- -
+ Interest Expense
1
2
3
4
1
1
1
1
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
2
- -
- -
- -
- -
- -
-2
- -
- -
- -
Pretax Income
-4
-14
-26
-7
-4
-3
-2
-2
-1
-9
-4
-3
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-4
-14
-26
-7
-4
-3
-2
-2
-1
-9
-4
-3
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-4
-14
-26
-7
-4
-3
-2
-2
-1
-9
-4
-3
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-4
-14
-26
-7
-4
-3
-2
-2
-1
-9
-4
-3
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-4
-14
-26
-7
-4
-3
-2
-2
-1
-9
-4
-3
EBIT
-3
-12
-20
-3
-3
-2
-1
-1
-4
-9
-4
-3
EBITDA
-3
-12
-20
-3
-3
-2
-1
-1
-4
-9
-4
-3
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-3
-12
-20
-3
-3
-2
-1
-1
-4
-9
-4
-3
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS from Cont Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted EPS from Cont Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Balance Sheet (USD)

APIChatGPT
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
4
2
1
1
1
- -
- -
7
8
4
4
6
+ Cash, Cash Equivalents & STI
3
1
1
1
1
- -
- -
7
8
3
3
5
+ Cash & Cash Equivalents
3
1
1
1
1
- -
- -
7
8
3
3
5
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
4
2
1
1
1
- -
- -
7
8
4
4
6
+ Payables & Accruals
- -
- -
- -
- -
- -
- -
2
- -
- -
1
- -
- -
+ Accounts Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
+ ST Debt
4
- -
1
- -
9
- -
12
- -
- -
- -
- -
- -
+ ST Borrowings
4
- -
1
- -
9
- -
12
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
2
- -
1
1
- -
- -
- -
2
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
2
- -
1
1
- -
- -
- -
2
- -
- -
- -
Total Current Liabilities
4
2
2
1
10
1
14
- -
3
1
- -
- -
+ LT Debt
4
5
8
8
- -
11
- -
- -
- -
- -
- -
- -
+ LT Borrowings
4
5
8
8
- -
11
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
4
5
8
8
- -
11
- -
- -
- -
- -
- -
- -
Total Liabilities
8
7
9
9
10
12
14
- -
3
1
- -
- -
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
8
20
42
49
55
55
55
77
78
84
89
94
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
8
20
42
49
55
55
55
77
78
84
89
94
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-12
-26
-52
-59
-64
-67
-69
-70
-72
-81
-85
-88
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-4
-6
-8
-8
-9
-12
-14
7
6
3
3
5
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-4
-6
-8
-8
-9
-12
-14
7
6
3
3
5
Total Liabilities & Equity
4
2
1
1
1
- -
- -
7
8
4
4
6
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
5
4
8
8
8
11
12
-7
-8
-3
-3
-5
Net Debt to Equity
-125.54
-69.84
-97.36
-89.8
-93.56
-95.18
-85.62
-101.52
-126.75
-104.14
-95.45
-99.2
Tangible Common Equity Ratio
-96.78
-367.27
-1,192.87
-1,055.2
-826.18
-38,497.49
- -
98.5
70.01
77.76
90.22
92.78
Current Ratio
0.98
0.72
0.47
0.83
0.11
0.05
- -
66.81
3.33
4.5
10.22
13.85
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-4
-14
-26
-7
-4
-3
-2
-2
-1
-9
-4
-3
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
3
10
18
3
- -
- -
1
1
-2
-1
- -
- -
+ Stock-Based Compensation
- -
4
10
-1
1
- -
- -
- -
- -
- -
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
2
7
9
4
- -
- -
1
- -
-2
-1
- -
- -
+ Chg in Non-Cash Work Cap
-1
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
- -
+ Inc (Dec) in Accts Payable
- -
- -
- -
1
- -
- -
- -
- -
- -
1
- -
- -
+ Inc (Dec) in Other
-1
- -
- -
- -
- -
- -
- -
- -
1
-1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-3
-4
-7
-3
-4
-3
- -
-1
-4
-10
-4
-3
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
2
1
4
- -
- -
7
4
5
3
5
+ Increase in Capital Stock
- -
- -
2
1
4
- -
- -
7
4
5
3
5
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
5
4
6
5
-1
5
- -
1
- -
- -
- -
- -
+ Cash From Debt
6
4
6
5
1
5
- -
1
- -
- -
- -
- -
+ Repayments of Debt
-1
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
-2
-2
-3
1
-2
- -
- -
- -
- -
2
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
5
2
7
3
4
2
- -
8
4
5
4
5
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
3
-2
- -
- -
- -
-1
- -
7
1
-5
- -
2
EBITDA
-3
-12
-20
-3
-3
-2
-1
-1
-4
-9
-4
-3
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-3
-4
-7
-3
-4
-3
- -
-1
-4
-10
-4
-3
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
-1
2
-5
1
- -
- -
-4
-10
-4
-3
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Price/Free Cash Flow
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash Flow to Net Income
0.62
0.26
0.28
0.47
0.93
0.95
0.23
0.76
2.4
1.07
1
0.87
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -